Salud
Los avances tecnológicos son cada vez mayores, lo que desafía el status quo del sector sanitario que esta avanzando a pasos agigantados. Pero en una industria tan regulada, las asociaciones estratégicas suelen ser la clave para desarrollar con éxito los negocios. Nuestros asesores, respaldados por equipos subsectoriales en todo el mundo, utilizan su profunda experiencia en fusiones y adquisiciones, levantamiento de cpaital y mercado de acciones, asesoramiento sobre la deuda y servicios de finanzas corporativas para encontrar su ventaja competitiva, navegar por las costumbres locales y ayudarle a crear la estrategia más adecuada.
Contacte al asesor
Clínica Ricardo Palma has sold a 50% stake to Quirónsalud
The shareholders of Administradora Clínica Ricardo Palma S.A. (Clínica Ricardo Palma) have sold 50% of their shares to Quirónsalud for an undisclosed consideration.
Conozca másOlyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Conozca másBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Conozca más
Jan De Backer
CEO, Fluidda NV
Leer más
Strategic steps, global reach: mid-market M&A in Q1
QUARTERLY M&A ACTIVITY: In Q1 2026, Oaklins' clients completed 44 transactions across sectors and regions, highlighting continued cross-border activity and a focus on growth, capital and strategic expansion.
Conozca más
Contáctenos
